Drug Shortage Report for TARO-ATORVASTATIN
| Report ID | 112531 |
| Drug Identification Number | 02313758 |
| Brand name | TARO-ATORVASTATIN |
| Common or Proper name | ATORVASTATIN |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-04-20 |
| Estimated end date | 2020-09-11 |
| Actual end date | 2020-09-16 |
| Shortage status | Resolved |
| Updated date | 2020-10-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v17 | 2020-10-08 | French | Compare |
| v16 | 2020-10-08 | English | Compare |
| v15 | 2020-08-28 | French | Compare |
| v14 | 2020-08-28 | English | Compare |
| v13 | 2020-07-28 | French | Compare |
| v12 | 2020-07-28 | English | Compare |
| v11 | 2020-07-03 | French | Compare |
| v10 | 2020-07-03 | English | Compare |
| v9 | 2020-06-01 | French | Compare |
| v8 | 2020-06-01 | English | Compare |
| v7 | 2020-05-27 | French | Compare |
| v6 | 2020-05-27 | English | Compare |
| v5 | 2020-05-01 | French | Compare |
| v4 | 2020-05-01 | English | Compare |
| v3 | 2020-04-21 | English | Compare |
| v2 | 2020-04-20 | French | Compare |
| v1 | 2020-04-20 | English | Compare |
Showing 1 to 17 of 17